Melatonin Ameliorates Liver Fibrosis Induced by Carbon Tetrachloride in Rats via Inhibiting TGF-β1/Smad Signaling Pathway

Abstract

Melatonin has been reported to inhibit hepatic fibrosis and the mechanism may be correlated to its anti-oxidant effect. Nevertheless, the mechanism is not completely identified. This study was conducted to investigate the effects of melatonin on TGF-β1/Smad signaling pathway in liver fibrosis in rats. The liver fibrosis model was made by the subcutaneous injection of CCl₄. The liver pathology changes were detected using hematoxylin and eosin (H&E) staining and Van Gieson (VG) staining. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were measured with an autoanalyzer. Glutathione peroxidase (GPx) activities and levels of malondialdehyde (MDA) and hydroxyproline (Hyp) in liver were evaluated by spectrophotometry. Expression levels of TGF-β1, Smad2/3, phosphorylated Smad2/3 (p-Smad2/3) and Smad7 in liver were detected by immunohistochemistry and Western blot analysis. Results showed that melatonin suppressed CCl₄-induced liver fibrosis, along with an improvement in histological changes, significant decreases in pathologic grading sores and obvious decreases in Hyp levels in liver. Melatonin improved liver function indicated by decreased serum ALT and AST activities. In addition, melatonin exerted its anti-oxidant effects, as supported by decreased MDA levels and increased GPx activities in liver. Furthermore, melatonin inhibited TGF-β1/Smad pathway, as evidenced by decreased TGF-β1, Smad2/3 and p-Smad2/3 expression and increased Smad7 expression in liver. In conclusion, melatonin may suppress CCl₄-induced hepatic fibrosis in rats via inhibiting TGF-β1/Smad pathway. It is possible for melatonin to be a potential reagent to treat and cure liver fibrosis.

Keywords

melatonin / liver fibrosis / TGF-β1 / Smad

References

[1] PellicoroA, RamachandranP, IredaleJP. Reversibility of liver fibrosis. Fibrogenesis Tissue Repair, 2010, 5(1): S26

[2] ZhouWC, ZhangQB, QiaoL. Pathogenesis of liver cirrhosis. World J Gastroenterol, 2014, 20(23): 7312-7324

[3] BaghyK, IozzoRV, KovalszkyI. Decorin-TGFbeta axis in hepatic fibrosis and cirrhosis. J Histoch m Cytochem, 2012, 60(4): 262-268

[4] LeeJH, JangEJ, SeoHL, et al.. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-beta/Smad signaling pathway. Chem Biol Interact, 2014, 224: 58-67

[5] KajdaniukD, MarekB, Borgiel-MarekH, et al.. Transforming growth factor beta1 (TGFbeta1) in physiology and pathology. Endokrynol Pol, 2013, 64(5): 384-396

[6] YaoQY, XuBL, WangJY, et al.. Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats. BMC Complement Altern Med, 2012, 12: 156

[7] GressnerAM, WeiskirchenR. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β β as major players and therapeutic targets. J Cell Mol Med, 2006, 10(1): 76-99

[8] GalanoA, TanDX, ReiterRJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res, 2011, 51(1): 1-16

[9] AllegraM, ReiterRJ, TanDX, et al.. The chemistry of melatonin’s interaction with reactive species. J Pineal Res, 2003, 34(1): 1-10

[10] TahanV, AtugO, AkinH, et al.. Melatonin ameliorates methionine-and choline-deficient diet-induced nonalcoholic steatohepatitis in rats. J Pineal Res, 2008, 46(4): 401-407

[11] HongRT, XuJM, MeiQ. Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats. World J Gastroenterol, 2009, 15(12): 1452-1458

[12] HongRT, XuJM, ShenJL, et al.. Effects of melatonin on hepatic fibrosis induced by carbon tetrachloride in rats and its mechanisms. Chin Pharm Bull (Chinese), 2012, 28(8): 1141-1145

[13] BedossaP, PoynardT. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology, 1996, 24(2): 289-293

[14] JiangY, WangC, LiYY, et al.. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-beta/Smad interference. J Ethnopharmacol, 2014, 158: 230-238

[15] RosaDP, BonaS, SimonettoD, et al.. Melatonin protects the liver and erythrocytes against oxidative stress in cirrhotic rats. Arq Gastroenterol, 2010, 47(1): 72-78

[16] SagorAT, ChowdhuryMR, TabassumN, et al.. Supplementation of fresh ucche (Momordica charantia L. var. muricata Willd) prevented oxidative stress, fibrosis and hepatic damage in CCl4 treated rats. BMC Complement Altern Med, 2015, 15: 115

[17] ParolaM, RobinoG. Oxidative stress-related molecules and liver fibrosis. J Hepatol, 2001, 35(2): 297-306

[18] TahanG, TarcinO, TahanV, et al.. The effects of N-acetylcysteine on bile duct ligation-induced liver fibrosis in rats. Dig Dis Sci, 2007, 52(12): 3348-3354

[19] MorsyMA, AbdallaAM, MahmoudAM, et al.. Protective effects of curcumin, alpha-lipoic acid, and N-acetylcysteine against carbon tetrachlorideinduced liver fibrosis in rats. J Physiol Biochem, 2012, 68(1): 29-35

[20] ClaustratB, BrunJ, ChazotG. The basic physiology and pathophysiology of melatonin. Sleep Med Rev, 2005, 9(1): 11-24

[21] HatzisG, ZiakasP, KavantzasN, et al.. Melatonin attenuates high fat diet-induced fatty liver disease in rats. World J Hepatol, 2013, 5(4): 160-169

[22] Tomás-ZapicoC, Coto-MontesA. Melatonin as antioxidant under pathological processes. Recent Pat Endocr Metab Immune Drug Discov, 2007, 1(1): 63-82

[23] ChoiHS, KangJW, LeeSM. Melatonin attenuates carbon tetrachloride-induced liver fibrosis via inhibition of necroptosis. Transl Res, 2015, 166(3): 292-303

[24] HuS, YinS, JiangX, et al.. Melatonin protects against alcoholic liver injury by attenuating oxidative stress, inflammatory response, and apoptosis. Eur J Pharmacol, 2009, 616(1-3): 287-292

[25] HongRT, ChenSL, RuanHL, et al.. Effects of melatonin on acute liver injury induced by ethanol in rats. Chin Pharm Bull (Chinese), 2011, 27(11): 1596-1599

[26] KohPO. Melatonin prevents hepatic injury-induced decrease in Akt downstream targets phosphorylations. J Pineal Res, 2011, 51(2): 214-219

[27] JungKH, HongSW, ZhengHM, et al.. Melatonin downregulates nuclear erythroid 2-related factor 2 and nuclear factor-kappaB during prevention of oxidative liver injury in a dimethylnitrosamine model. J Pineal Res, 2009, 47(2): 173-183

[28] TahanG, AkinH, AydoganF, et al.. Melatonin ameliorates liver fibrosis induced by bile-duct ligation in rats. Can J Surg, 2010, 53(5): 313-318

[29] LeaskA, AbrahamDJ. TGF-beta signaling and the fibrotic response. FASEB J, 2004, 18(7): 816-827

[30] FanX, ZhangQ, LiS, et al.. Attenuation of CCl4-induced hepatic fibrosis in mice by vaccinating against TGF-beta1. PLoS One, 2013, 8(12): e82190

[31] HuangW, LiL, TianX, et al.. Astragalus and Paeoniae Radix Rubra extract (APE) inhibits hepatic stellate cell activation by modulating transforming growth factor-beta/Smad pathway. Mol Med Rep, 2015, 11(4): 2569-2577

[32] XuMY, HuJJ, ShenJ, et al.. Stat3 signaling activation crosslinking of TGF-beta1 in hepatic stellate cell exacerbates liver injury and fibrosis. Biochim Biophys Acta, 2014, 1842(11): 2237-2245

[33] SferraR, VetuschiA, CatittiV, et al.. Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGFbeta1 downregulation. Eur Rev Med Pharmacol Sci, 2012, 16(11): 1484-1498

[34] ChenBL, PengJ, LiQF, et al.. Exogenous bone morphogenetic protein-7 reduces hepatic fibrosis in Schistosoma japonicum-infected mice via transforming growth factor-beta/Smad signaling. World J Gastroenterol, 2013, 19(9): 1405-1415

[35] DooleyS, DijkePT. TGF-beta in progression of liver disease. Cell Tissue Res, 2012, 347(1): 245-256

[36] LiJ, LiX, XuW, et al.. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFbeta/Smad signalling pathways. Liver Int, 2015, 35(4): 1222-1233